MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ATXI
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Avenue Therapeutics (ATXI) Ownership - Who owns Avenue Therapeutics?

Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.28M
P/E Ratio
0.38
Total Cash
3.71M
Projected Growth
N/A
Total Debt
6.38M
Revenue
1.4M
Risk (Beta)
3.19
Dividend Yield
N/A
Total Cash/Share
1.13
Total Debt/Equity
N/A
Revenue/Share
0.45 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ATXI
A.I. Advisor
published General Information

General Information

a pharmaceutical company

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A